AbbVie
ABBV
#30
Rank
C$443.53 B
Marketcap
$250.99
Share price
2.18%
Change (1 day)
22.26%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Net assets

Net assets on the balance sheet as of September 2024 : C$8.68 Billion

According to AbbVie's latest financial reports the company has C$8.68 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

AbbVie - Net assets on balance sheet (from 2011 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$C$13.79 B-41.21%
2022-12-31$C$23.45 B19.24%
2021-12-31$C$19.67 B17.8%
2020-12-31$C$16.69 B-256.46%
2019-12-31$-C$10.68 Billion-7.23%
2018-12-31$-C$11.51 Billion-279.54%
2017-12-31$C$6.40 B2.86%
2016-12-31$C$6.23 B13.84%
2015-12-31$C$5.47 B170.71%
2014-12-31$C$2.02 B-57.72%
2013-12-31$C$4.78 B42.99%
2012-12-31$C$3.34 B-72.45%
2011-12-31$C$12.13 B-22.68%
2010-12-31$C$15.69 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
C$132.46 B 1,424.59%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.61 B 183.31%๐Ÿ‡บ๐Ÿ‡ธ USA
C$20.49 B 135.89%๐Ÿ‡บ๐Ÿ‡ธ USA
C$10.77 B 23.98%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.31 B 202.92%๐Ÿ‡บ๐Ÿ‡ธ USA
C$23.41 B 169.46%๐Ÿ‡บ๐Ÿ‡ธ USA
C$25.76 B 196.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$58.39 B 572.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$3.89 B-55.21%๐Ÿ‡บ๐Ÿ‡ธ USA